Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 8Breast Neoplasms 6Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 3Neoplasms 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Recurrence 2Melanoma 2Lung Neoplasms 2Solid Tumors 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Nervous System Neoplasms 1Locally Advanced Rectal Cancer 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Central Nervous System Diseases 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Brain Metastases From Non-small Cell Lung Cancer 1Brain Diseases 1Advanced Solid Tumors 1

Interventions

Injections 25Carboplatin 17Docetaxel 14pembrolizumab 12Paclitaxel 11Bevacizumab 9durvalumab 8Cisplatin 8Nivolumab 6Fluorouracil 6trifluridine tipiracil drug combination 5tislelizumab 5linifanib 5Pemetrexed 5Oxaliplatin 5Leucovorin 5zimberelimab 4toripalimab 4talazoparib 4olaparib 4Itraconazole 4Irinotecan 4Gemcitabine 4Capecitabine 4tremelimumab 3sotorasib 3sintilimab 3fludarabine 3depatuxizumab 3atezolizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Advanced Solid Tumors × veliparib × Clear all
NCT01063816 2021-08-02

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

AbbVie

Phase 1 Completed
79 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡